Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suppressor T cells in allogeneic bone marrow chimeras.

B Leshem1, Z Lebendiker, L Weiss

  • 1Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Bone Marrow Transplantation
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When can temporally focused excitation be axially shifted by dispersion?

Optics express·2014
Same author

Visual characterization of recombination at FRT-gusA loci in transgenic tobacco mediated by constitutive expression of the native FLP recombinase.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

Vaccine·2001
Same author

Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines.

Biochimica et biophysica acta·2001
Same author

Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects.

Biochimica et biophysica acta·2001
Same author

Correlation between enhancement of graft-versus-leukemia effects following allogeneic bone marrow transplantation by rIL-2 and increased frequency of cytotoxic T-lymphocyte precursors in murine myeloid leukemia.

Cytokines, cellular & molecular therapy·2001
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
See all related articles

Bone marrow chimeras utilize immunosuppression to maintain stability. Donor lymphocytes suppress recipient immune responses, with specific cell types mediating this effect over time.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cellular Immunology

Background:

  • Stable bone marrow chimeras are thought to rely on immunosuppression.
  • Understanding the mechanisms of this suppression is crucial for transplantation success.

Purpose of the Study:

  • To investigate the nature and specificity of lymphocyte-mediated suppression in allogeneic bone marrow chimeras.
  • To determine how this suppression affects donor and recipient lymphocytes' alloreactivity.

Main Methods:

  • CBA/J mice received allogeneic bone marrow cells (unseparated or T cell-depleted).
  • Spleen cells from chimeras were co-cultured with normal donor, recipient, or third-party cells.
  • Proliferative and cytotoxic responses against foreign antigens were measured.

Related Experiment Videos

Main Results:

  • Early post-transplant, both chimera types non-specifically suppressed alloreactivity.
  • Later, chimeras suppressed recipient-type responses, and WBM chimeras suppressed donor-type responses.
  • Donor-type suppression waned, while recipient-type suppression persisted for at least 10 weeks.

Conclusions:

  • Allogeneic bone marrow chimeras develop specific suppressive mechanisms.
  • Donor-derived radioresistant and radiosensitive cells mediate suppression of recipient and donor alloreactivity, respectively.
  • These findings offer insights into the biological role of suppression in allogeneic engraftment.